Intravenous Ketamine Plus Neurocognitive Training for Depression
Status:
Active, not recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
This study has two aims: 1) to characterize the effects of intravenous ketamine on
neurocognitive markers in depressed patients; 2) to test the efficacy of a synergistic
intervention for depression combining intravenous ketamine with neurocognitive training.